Skip to main content

Table 2 Potential predictors of the response to steroid in patients with brain necrosis

From: A radiomics model for predicting the response to methylprednisolone in brain necrosis after radiotherapy for nasopharyngeal carcinoma

Variable

Univariate logistic regression

Multivariate logistic regression

OR (95%CI)

P*

OR (95%CI)

P

Age, years

1.008 (0.954–1.065)

0.774

  

Sex

 

0.955

  

  Male

Reference

   

  Female

0.965 (0.282–3.302)

   

Radiomics score (per 0.1 increase)

2.172 (0.476–9.916)

 < 0.001*

3.388 (0.538–21.334)

 < 0.001

DBRN, months

0.992 (0.983–1.000)

0.050*

1.020 (1.001–1.040)

0.034

DBRM, months

0.997 (0.981–1.012)

0.664

  

DBNM, months

0.992 (0.958–1.028)

0.674

  

AST, U/L

1.029 (0.939–1.128)

0.543

  

ALT, U/L

0.989 (0.942–1.038)

0.655

  

Hs-CRP, mg/L

0.999 (0.978–1.021)

0.947

  

Dmax of the GTVnx,Gy

1.130 (0.910–1.404)

0.269

  

Dmax of the GTVnd,Gy

1.082 (0.947–1.237)

0.246

  

Dmax of the temporal lobe, Gy

0.982 (0.827–1.167)

0.838

  

Radiotherapy methods

 

0.481

  

  Conventional radiotherapy

Reference

   

  IMRT

0.545 (0.101–2.944)

   

MOCA

 

0.048*

  

  < 26

Reference

   

  ≥ 26

0.357 (0.129–0.992)

   

LENT-SOMA#

0.917 (0.840–1.000)

0.050*

  

NPC stage

 

0.469

  

  II

Reference

   

  III

4.286 (0.438–41.954)

0.211

  

  IV

2.000 (0.191–20.898)

0.563

  

  IVA

3.125 (0.278–35.157)

0.356

  

Steroid dose, mg/d

 

0.246

  

  80

Reference

   

  500

1.833 (0.658–5.107)

   
  1. DBRN, duration between radiotherapy and radiation-induced brain necrosis (RN) diagnosis; DBRM, duration between radiotherapy and methylprednisolone treatment; DBNM, duration between RN diagnosis and methylprednisolone treatment; AST, aspartate transaminase; ALT, alanine transaminase; Hs-CRP, high-sensitivity C-reaction protein levels; Dmax of the GTVnx, the maximum radiation dose of the nasopharynx; Dmax of the GTVnd, the maximum radiation dose of the neck; IMRT, intensity-modulated radiation therapy; MoCA, montreal cognitive assessment score; LENT-SOMA, the late effects of normal tissue (LENT)/subjective, objective, management, analytic (SOMA) scale score; NPC, nasopharyngeal carcinoma
  2. *P < 0.02; #summary grade of the Subjective, Objective, and Management (SOM) characteristics